National Alliance for Medication Assisted Recovery

National Alliance for Medication Assisted Recovery
CONFIDENTIAL
Grievance/Compliment Report

All information that is provided will be held strictly confidential in the same manner as the patient protections described in the U.S. Federal Confidentiality Regulations 42 CFR and the Standards for Privacy of Individually Identifiable Health Information (the Privacy Rule) as established by the Department of Health and Human Services (HHS) under the Health Insurance Portability and Accountability Act of 1996 (HIPAA). In order to assist you at the maximum level of follow-up and outcome, we do request certain personal information below. However, if you do not want us to disclose your name for any reason, we will honor your wishes.


Information on Person Filing Report

Name:  _____________________________________________________________________________

Address:  ___________________________________________________________________________

City:  ________________________  State/Providence: ____  Zip/Postal Code: _____ Country:_________

Phone:  __________________________________    Fax:  ___________________________________

Other Phone:  _______________________________  Email:  ________________________________
If we contact the clinic or agency do you want to be informed of the
results? (If by mail please include a self-addressed envelope.)   Yes  ________  No  ________

Information About Agency Under Report

Name of Clinic/Agency:  ______________________________________________________________

Address:  _________________________________________________________________________

City:  _____________________   State/Providence:  _____   Zip/Postal Code:  ______   Country:  ______

Phone:  __________________________________      Fax:  __________________________________

Name/Title of Person to Contact:  ______________________________________________________

Type of Program/Agency, Check Only One:
Program
Supportive Services
State Agency
Other _____________________________

Information About Incident
Category of Incident Choose One Below:
Date of Incident: ____________________
Threat of Termination/Discharge
Dosage Policies
Urine Testing Procedures
Punitive Staff
Medication Hours or Schedule
Pick-up Schedule Problems
Unfair or Exorbitant Cost of Treatment
Other, describe: __________

Please Describe Incident in a Concise Way.


By filing an Grievance/Compliment Report you are helping NAMA keep track of programs and how they are operating. If you need help you should contact NAMA immediately at (212) 595-6262. NAMA does investigate all Grievance/Compliment Reports and discusses patterns of Grievances with regulatory agencies and professional organizations.

Policies that are beneficial or incidents that were managed well by a program may also be reported. These reports will be used to demonstrate alternative policies that can be used by programs and to commend the program that has developed and used them.

Please complete and mail to: Claude Hopkins, Grievance Coordinator
Email:
[email protected]

National Alliance of Methadone Advocates
435 Second Avenue
New York, NY 10010
Phone/Fax: (212) 595-nama

Together, we can make a difference.


NAMA Information                 Investigator: _________________________________________

Date Received:

Date Completed:          Report  Yes ___ No ___     Initial Upon Completion ________

Comments:

Similar Posts

  • Affordable Care Act

    Admin 08/28/2021

    Resources  Equal Parity On March 23, 2010, President Obama signed the Affordable Care Act (ACA) into law. This puts in place comprehensive health insurance reforms that will roll out over four years and beyond. Health reform includes several key steps in the next 4 years. Medicaid will be expanded to allow more people at the lowest…

  • The National Methadone Conference-5

    Admin 12/15/2022

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Workshop April 15, 2003 Medication – Assisted Treatment in Different Practice Settings: Patients’ Perspectives Joycelyn Woods, National Alliance of Methadone Advocates, Facilitator NAMA representativees will discuss the administration of methadone in a variety of settings. Topics will include the patients’…

  • Hepatitis C Committee

    Admin 06/24/2023

    Chair: Dr. P. Kishore, MD, MPH, CMA (Boston NAMA) Committee Members Paul Bowman, CMA  Cheri Jarvis, CMA  Hepatitis C Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can…

  • We Remember

    Admin 09/17/2022

    Hector Valentin Maldonado February 14, 1942 – August 14, 2003 Acting President, 1996 – 1998 Acting Treasurer, 1995 – 1996 Vice President, 1989 – 1996 Hector Maldonado was a founding member of NAMA. He was a member of the committee during the first year that met when patients and professionals discussed the need to start…

  • On the Issue of Raising a Patient’s Dose Without Their Consultation

    Admin 06/16/2022

    Policy Statement Number 5 March 1995 Numerous studies have shown that dose is one of the most important aspects of methadone treatment and that patients who are given an adequate dose, know their dose and have some influence regarding their dose do better in treatment and remain in treatment (Ball and Ross, 1994; Caplehorn and…